Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Focus Financial Partners Inc is a capital markets business based in the US. Focus Financial Partners shares (FOCS) are listed on the NASDAQ and all prices are listed in US Dollars. Focus Financial Partners employs 3,600 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$61.48|
|52-week range||$35.56 - $60.00|
|50-day moving average||$53.52|
|200-day moving average||$50.18|
|Wall St. target price||$66.38|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.14|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||5.26%|
|1 month (2021-09-23)||19.03%|
|3 months (2021-07-23)||22.69%|
|6 months (2021-04-23)||33.16%|
|1 year (2020-10-23)||53.74%|
|2 years (2019-10-23)||177.81%|
|3 years (2018-10-23)||51.13%|
|5 years (2016-10-19)||N/A|
Valuing Focus Financial Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Focus Financial Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Focus Financial Partners's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 429x. In other words, Focus Financial Partners shares trade at around 429x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Focus Financial Partners's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $345.2 million.
The EBITDA is a measure of a Focus Financial Partners's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.5 billion|
|Operating margin TTM||11.01%|
|Gross profit TTM||$535.6 million|
|Return on assets TTM||3.48%|
|Return on equity TTM||2.23%|
|Market capitalisation||$4.2 billion|
TTM: trailing 12 months
There are currently 2.7 million Focus Financial Partners shares held short by investors – that's known as Focus Financial Partners's "short interest". This figure is 7.6% up from 2.5 million last month.
There are a few different ways that this level of interest in shorting Focus Financial Partners shares can be evaluated.
Focus Financial Partners's "short interest ratio" (SIR) is the quantity of Focus Financial Partners shares currently shorted divided by the average quantity of Focus Financial Partners shares traded daily (recently around 373051.4986376). Focus Financial Partners's SIR currently stands at 7.34. In other words for every 100,000 Focus Financial Partners shares traded daily on the market, roughly 7340 shares are currently held short.
However Focus Financial Partners's short interest can also be evaluated against the total number of Focus Financial Partners shares, or, against the total number of tradable Focus Financial Partners shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Focus Financial Partners's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Focus Financial Partners shares in existence, roughly 40 shares are currently held short) or 0.0527% of the tradable shares (for every 100,000 tradable Focus Financial Partners shares, roughly 53 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Focus Financial Partners.
Find out more about how you can short Focus Financial Partners stock.
We're not expecting Focus Financial Partners to pay a dividend over the next 12 months.
Over the last 12 months, Focus Financial Partners's shares have ranged in value from as little as $35.56 up to $60. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Focus Financial Partners's is 1.1776. This would suggest that Focus Financial Partners's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Focus Financial Partners Inc. provides wealth management services to primarily ultra-high and high net worth individuals, families, and business entities. Its wealth management services include investment advice, financial and tax planning, consulting, tax return preparation, family office services, and other services. The company also offers recordkeeping and administration services; recommends financial products through commissions and distribution fees; and sells investment or insurance products. The company was founded in 2006 and is headquartered in New York, New York. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.